Approved by the FDA in recent years, tirzepatide is a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors
Dr Harish is a Celebrity Aesthetic Physician and Surgeon, having worked with numerous South Indian film personalities while maintaining a patient-first approach that blends artistry with medical precision
doi: 10.1021/acsnano.4c04901 Summary Keywords diabetic cardiomyopathy, ferroptosis, mitochondrial damage, molecular mechanisms, targeted therapy, combination therapy, clinical applications Citation Liu B, Jin Q, Sun YK, Yang ZM, Meng P, Zhang X, Chen Q, Gan P, Zhao T, He JJ, He GP and Xue Q (2025) From bench to bedside: targeting ferroptosis and mitochondrial damage in the treatment of diabetic cardiomyopathy
Second, the peptide may reduce muscle contractions that contribute to dynamic wrinkle formation, similar to but much weaker than botulinum toxin effects
Psychiatry 17 (10), 10171025